ZYNTEGLO
STN: 125717
Proper Name: betibeglogene autotemcel
Tradename: ZYNTEGLO
Manufacturer: bluebird bio Inc.
Indication:
- For treatment of adult and pediatric patients with ß-thalassemia who require regular red blood cell (RBC) transfusions
Product Information
Supporting Documents
- August 17, 2022 Approval Letter - ZYNTEGLO
- August 17, 2022 Summary Basis for Regulatory Action - ZYNTEGLO
- Approval History, Letters, Reviews and Related Documents - ZYNTEGLO